title: Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats.
abstract: Carbamazepine produces dose-related anticonvulsant effects in epilepsy models including the genetically epilepsy-prone rat (GEPR) model and the rat maximal electroshock model. Dose-response relationships are quantitatively different among the models. Against electroshock seizures in Sprague-Dawley rats the ED50 dose is 7.5 mg/kg whereas the ED50 against audiogenic seizures in severe seizure GEPRs (GEPR-9s) is 3 mg/kg. In contrast, the ED50 in moderate seizure GEPRs (GEPR-3s) is 25 mg/kg. The present study was designed to ascribe dose-response differences among the three rat strains to pharmacokinetic or pharmacodynamic factors. After systemic carbamazepine, pharmacokinetic studies revealed differences in area under the concentration-vs.-time curve. In other experiments, carbamazepine-induced serotonin release from hippocampus was used as a pharmacodynamic marker. In a concentration-controlled design using intracerebral microdialysis, hippocampal carbamazepine infusions produced similar concentration-response relations for the three rat strains. These data support the hypothesis that dose-response differences among the three rat strains are primarily pharmacokinetic in nature.
authors.affiliation: Department of Biomedical and Therapeutic Sciences and Medicine, University of Illinois, College of Medicine at Peoria, 61656, USA. jfg@uic.edu
authors.forename: J F
authors.initials: JF
authors.lastname: Graumlich
authors.forename: R G
authors.initials: RG
authors.lastname: McLaughlin
authors.forename: D
authors.initials: D
authors.lastname: Birkhahn
authors.forename: N
authors.initials: N
authors.lastname: Shah
authors.forename: A
authors.initials: A
authors.lastname: Burk
authors.forename: P C
authors.initials: PC
authors.lastname: Jobe
authors.forename: J W
authors.initials: JW
authors.lastname: Dailey
mesh_terms: D000161:Acoustic Stimulation; D000818:Animals; D000927:Anticonvulsants / Q000493:pharmacokinetics* / Q000494:pharmacology*; D019540:Area Under Curve; D002220:Carbamazepine / Q000493:pharmacokinetics* / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004827:Epilepsy / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D006207:Half-Life; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D007274:Injections, Intraperitoneal; D017551:Microdialysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D012701:Serotonin / Q000378:metabolism; D013045:Species Specificity
chemical_list: D000927:Anticonvulsants; D012701:Serotonin; D002220:Carbamazepine